Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Colorectal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The study is an open label phase 2 clinical trial with 2 independent study arms conducted through the University of Wisconsin Carbone Cancer CenterMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04587128
- Collaborators
- Doris Duke Charitable Foundation
- Investigators
- Principal Investigator: Dustin Deming, MD University of Wisconsin, Madison
Get Well Soon